ScholarX

Journal of Clinical Oncology

Journal Title

  • Journal of Clinical Oncology

ISSN

  • E 1527-7755 | P 0732-183X

Publisher

  • American Society of Clinical Oncology

Listed on(Coverage)

JCR 1997-2023
SJR 1999-2020;2022-2023
CiteScore 2011-2023
SCI 2010-2019
SCIE 2010-2024
CC 2016-2024
SCOPUS 2017-2024
MEDLINE 2016-2024
EMBASE 2016-2024

Active

  • Active

    based on the information

    • SCOPUS:2024-10

Country

  • USA

Aime & Scopes

  • JCO publishes original research, reviews and other material related to breast cancer, gastrointestinal cancer, hematologic malignancies, molecular oncology, lung cancer, genitourinary cancer, head and neck cancer, pediatric oncology, neurooncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readership comprises practicing clinical oncologists, researchers, students, individuals in training, and allied health professionals throughout the world. Members of the American Society of Clinical Oncology as well as nonmember subscribers and patrons of medical libraries globally utilize the groundbreaking research published in each issue of JCO.

Homepage

Article List

921 - 940 out of 1,024 results.

SCIESCOPUS
Phase Ib study of ficlatuzumab (formerly AV-299), an anti-hepatocyte growth factor (HGF) monoclonal antibody (MAb) in combination with gefitinib (G) in Asian patients (pts) with NSCLC.

Tan, E[Tan, E.]; Park, K[Park, K.]; Lim, WT[Lim, W. T.]; Ahn, M[Ahn, M.]; Ng, QS[Ng, Q. S.]; Ahn, JS[Ahn, J. S.]; Tan, DS[Tan, D. S.]; Sun, J[Sun, J.]; Jac, J[Jac, J.]; Han, M[Han, M.], et al.

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
An open-label phase II study of intravenous bortezomib and oral panobinostat (LBH589) in adult patients with relapsed/refractory peripheral T-cell lymphoma (PTCL) or NK/T-cell lymphoma (NKL) after failure of conventional chemotherapy.

Tan, DC[Tan, D. C.]; Chan, P[Chan, P.]; Ng, BL[Ng, B. L.]; Yap, BK[Yap, B. K.]; Chan, YH[Chan, Y. H.]; Koh, LP[Koh, L. P.]; Wahid, FA[Wahid, F. A.]; Lim, ST[Lim, S. T.]; Chin, NS[Chin, N. S.]; Kim, WS[Kim, W. S.], et al.

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Profiling signal transduction pathways in ascites tumor cells of gastric cancer.

Lee, J[Lee, J.]; Kim, PS[Kim, P. S.]; Sun, JM[Sun, J. M.]; Liu, L[Liu, L.]; Park, SH[Park, S. H.]; Fithian, A[Fithian, A.]; Park, JO[Park, J. O.]; Magonova, K[Magonova, K.]; Lim, HY[Lim, H. Y.]; Liu, X[Liu, X.], et al.

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
A multicenter, randomized phase III trial comparing second-line chemotherapy (SLC) plus best supportive care (BSC) with BSC alone for pretreated advanced gastric cancer (AGC)

Park, SH[Park, S. H.]; Lim, DH[Lim, D. H.]; Park, K[Park, K.]; Lee, S[Lee, S.]; Oh, SY[Oh, S. Y.]; Kwon, H[Kwon, H.]; Kang, JH[Kang, J. H.]; Hwang, IG[Hwang, I. G.]; Lee, J[Lee, J.]; Park, JO[Park, J. O.], et al.

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Prognostic factors in elderly patients with advanced non-small cell lung cancer treated with platinum-based doublet chemotherapy.

Yi, SY[Yi, S. Y.]; Ahn, M[Ahn, M.]; Park, JY[Park, J. Y.]; Lee, HR[Lee, H. R.]; Lee, J[Lee, J.]; Park, YH[Park, Y. H.]; Ahn, JS[Ahn, J. S.]; Park, K[Park, K.]

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Phase II study of sunitinib as second-line treatment in advanced biliary tract carcinoma: Multicenter, multinational study.

Yi, J[Yi, J.]; Thongprasert, S[Thongprasert, S.]; Doval, D[Doval, D.]; Lee, J[Lee, J.]; Cho, MN[Cho, M. N.]; Park, SH[Park, S. H.]; Park, JO[Park, J. O.]; Park, YS[Park, Y. S.]; Kang, WK[Kang, W. K.]; Lim, HY[Lim, H. Y.]

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Significance of thymidylate synthase and thyroid transcription factor 1 expression in patients with nonsquamous non-small cell lung cancer treated with pemetrexed-based chemotherapy.

Sun, J[Sun, J.]; Ahn, JS[Ahn, J. S.]; Park, K[Park, K.]; Han, JH[Han, J. H.]; Ahn, M[Ahn, M.]

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Imatinib efficacy by tumor genotype in Asian patients with metastatic or recurrent gastrointestinal stromal tumors (GISTs): A retrospective study of Korean GIST Study Group (KGSG).

Kang, HJ[Kang, H. J.]; Ryu, M[Ryu, M.]; Kim, K[Kim, K.]; Park, YS[Park, Y. S.]; Kim, WH[Kim, W. H.]; Im, S[Im, S.]; Park, SH[Park, S. H.]; Lee, KH[Lee, K. H.]; Song, H[Song, H.]; Kang, Y[Kang, Y.]

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
A phase III, open-label, randomized comparison of AS1413 (amonafide L-malate) plus cytarabine with daunorubicin plus cytarabine in secondary acute myeloid leukemia (ACCEDE)

Stone, RM[Stone, R. M.]; Allen, SL[Allen, S. L.]; Pigneux, A[Pigneux, A.]; Stuart, RK[Stuart, R. K.]; Wetzler, M[Wetzler, M.]; Rizzieri, D[Rizzieri, D.]; Erba, HP[Erba, H. P.]; Damon, LE[Damon, L. E.]; Jang, JH[Jang, J. H.]; Tallman, MS[Tallman, M. S.], et al.

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
A randomized phase III study of sox (S-1/oxaliplatin) versus COX (capecitabine/oxaliplatin) in patients with advanced colorectal cancer

Park, YS[Park, Y. S.]; Lim, HY[Lim, H. Y.]; Lee, J[Lee, J.]; Kim, TW[Kim, T. W.]; Lee, J[Lee, J.]; Hong, YS[Hong, Y. S.]; Kim, SY[Kim, S. Y.]; Baek, JY[Baek, J. Y.]; Kim, JH[Kim, J. H.]; Lee, K[Lee, K.], et al.

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
CA 15-3 elevations according to breast cancer subtypes at initial diagnosis of metastatic breast cancer (MBC)

Park, S[Park, S.]; Ahn, HK[Ahn, H. K.]; Lim, T[Lim, T.]; Park, YH[Park, Y. H.]; Ahn, JS[Ahn, J. S.]; Im, Y[Im, Y.]

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
A phase II study of sorafenib in patients with metastatic or unresectable gastrointestinal stromal tumors with failure of both imatinib and sunitinib: A KGSG study.

Ryu, M[Ryu, M.]; Park, SH[Park, S. H.]; Ryoo, B[Ryoo, B.]; Im, S[Im, S.]; Kwon, H[Kwon, H.]; Lee, SS[Lee, S. S.]; Park, SR[Park, S. R.]; Kang, BW[Kang, B. W.]; Kang, Y[Kang, Y.]

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Phase III study of gemcitabine/oxaliplatin (GEMOX) with or without erlotinib in unresectable, metastatic biliary tract carcinoma.

Lim, HY[Lim, H. Y.]; Lee, J[Lee, J.]; Chang, H[Chang, H.]; Kim, JS[Kim, J. S.]; Choi, HJ[Choi, H. J.]; Lee, MA[Lee, M. A.]; Jang, J[Jang, J.]; Jeung, H[Jeung, H.]; Kang, JH[Kang, J. H.]; Lee, HW[Lee, H. W.], et al.

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Prognostic impact on FOXP3 expression in triple-negative breast cancer (TNBC)

Lee, S[Lee, S.]; Park, YH[Park, Y. H.]; Cho, EY[Cho, E. Y.]; Ham, YH[Ham, Y. H.]; Seo, JJ[Seo, J. J.]; Ahn, JS[Ahn, J. S.]; Im, Y[Im, Y.]

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Fluoropyrimidine/platinum-based first-line chemotherapy in metastatic esophageal squamous cell carcinoma: Prognostic factor analysis in 239 patients.

Jung, HA[Jung, H. A.]; Lee, J[Lee, J.]; Ahn, HK[Ahn, H. K.]; Park, SH[Park, S. H.]; Park, YH[Park, Y. H.]; Im, Y[Im, Y.]

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
AVAPERL1 (MO22089): Maintenance (mtc) bevacizumab (bev) with or without pemetrexed (pem) in patients (pts) with advanced nonsquamous non-small cell lung cancer (nsNSCLC) treated with first-line (1L) bev-cisplatin (cis)-pem: Interim safety data.

Barlesi, F[Barlesi, F.]; Scherpereel, A[Scherpereel, A.]; Gervais, R[Gervais, R.]; Gorbunova, VA[Gorbunova, V. A.]; Vikstrom, A[Vikstroem, A.]; Ahn, M[Ahn, M.]; Kim, J[Kim, J.]; Chella, A[Chella, A.]; Aerts, J[Aerts, J.]; Ferrer, N[Ferrer, N.], et al.

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Prognostic index for patients with brain metastases from breast cancer: A validation and refinement of the breast-specific graded prognostic assessment (GPA) index

Ahn, HK[Ahn, H. K.]; Lee, S[Lee, S.]; Sohn, JH[Sohn, J. H.]; Park, S[Park, S.]; Ham, YH[Ham, Y. H.]; Seo, JJ[Seo, J. J.]; Cho, EY[Cho, E. Y.]; Nam, DH[Nam, D. H.]; Lee, JI[Lee, J. I.]; Choi, DH[Choi, D. H.], et al.

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Initial phase II results with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC): PROFILE 1005

Crino, L[Crino, L.]; Kim, D[Kim, D.]; Riely, GJ[Riely, G. J.]; Janne, PA[Janne, P. A.]; Blackhall, FH[Blackhall, F. H.]; Camidge, DR[Camidge, D. R.]; Hirsh, V[Hirsh, V.]; Mok, T[Mok, T.]; Solomon, BJ[Solomon, B. J.]; Park, K[Park, K.], et al.

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
A comprehensive profiling of colorectal cancer patients through multiplexed functional pathway signature and somatic mutation analysis for effective therapy selection

Kim, HC[Kim, H. C.]; Kim, PS[Kim, P. S.]; Princen, F[Princen, F.]; Meyer, G[Meyer, G.]; Webster, E[Webster, E.]; Brown, S[Brown, S.]; Kirkland, R[Kirkland, R.]; Zhou, J[Zhou, J.]; Triggs, C[Triggs, C.]; Liu, X[Liu, X.], et al.

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Treatment outcomes of chemotheraphy for advanced gastric cancer with disseminated intravascular coagulation

Lee, K[Lee, K.]; Hwang, IG[Hwang, I. G.]; Jang, J[Jang, J.]; Park, SH[Park, S. H.]; Kang, JH[Kang, J. H.]; Oh, SY[Oh, S. Y.]; Kwon, H[Kwon, H.]; Lim, DH[Lim, D. H.]; Park, K[Park, K.]; Lee, S[Lee, S.]

ArticleIssue Date2011CitationJOURNAL OF CLINICAL ONCOLOGY, v.29, no.15PublisherAMER SOC CLINICAL ONCOLOGY
first 41 42 43 44 45 46 47 48 49 50 last
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어